F2 Bio Td, Llc - Net Worth and Insider Trading

F2 Bio Td, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, F2 Bio Td, Llc owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .

Click here to see the complete history of F2 Bio Td, Llc’s form 4 insider trades.

Insider Ownership Summary of F2 Bio Td, Llc

Ticker	Company	Transaction Date	Type of Owner
CGEM	Cullinan Therapeutics Inc	2021-01-07	10 percent owner

F2 Bio Td, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

F2 Bio Td, Llc Ownership Network

Ownership Network List of F2 Bio Td, Llc

No Data

Ownership Network Relation of F2 Bio Td, Llc

F2 Bio Td, Llc Owned Company Details

What does Cullinan Therapeutics Inc do?

Who are the key executives at Cullinan Therapeutics Inc?

F2 Bio Td, Llc is the 10 percent owner of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include director & President and CEO Nadim Ahmed , Chief Legal Officer Jacquelyn L Sumer , and Chief Medical Officer Jeffrey Alan Jones .

Cullinan Therapeutics Inc (CGEM) Insider Trades Summary

Over the past 18 months, F2 Bio Td, Llc made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 105,995 shares made by Jennifer Michaelson , a net sale of 11,773 shares made by Jeffrey Alan Jones , and a net sale of 8,928 shares made by Jacquelyn L Sumer .

In summary, during the past 3 months, insiders sold 24,936 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 24,936 shares. During the past 18 months, 276,141 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 276,141 shares.

Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cullinan Therapeutics Inc Insider Transactions

No Available Data

F2 Bio Td, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for F2 Bio Td, Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, F2 Bio Td, Llc's mailing address is: New York Ny 10018.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.